Related Experiment Video
Updated: Mar 19, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.9K
Targeting Cell Death Pathways for Therapeutic Intervention in Kidney Diseases
1Product Development, Departments of Immunology, Infectious Diseases, and Ophthalmology, Genentech, South San Francisco, CA.
Seminars in Nephrology
|June 25, 2016
Summary
Precise control of cell death is vital for health. In kidney diseases, regulated necrosis pathways like necroptosis and ferroptosis are key targets for developing new therapies.
Area of Science:
- * Molecular Biology
- * Cellular Biology
- * Pathology
Background:
- * Accurate regulation of cell death and survival is crucial for maintaining organismal homeostasis, development, and immune function.
- * Dysregulated cell death contributes to various diseases, including developmental defects, neuropathies, infections, and cancer.
- * Kidney diseases, particularly acute conditions like ischemia-reperfusion injury, are significantly impacted by the aberrant regulation of cell death pathways.
Purpose of the Study:
- * To analyze cell death pathways implicated in kidney diseases.
- * To differentiate the importance of various cell death pathways in these pathologies.
- * To identify pathways with significant impact and therapeutic potential for kidney disease treatment.
Main Methods:
- * Review and analysis of cell death pathways activated in kidney diseases.
- * Comparative assessment of the roles of apoptosis and regulated necrosis in kidney pathologies.
- * Evaluation of therapeutic strategies targeting cell death pathways.
Main Results:
- * While classical apoptosis remains relevant, regulated necrosis pathways (necroptosis, ferroptosis, parthanatos, mitochondrial permeability transition-associated cell death) play a critical role in kidney diseases, especially acute kidney injury.
- * Receptor-interacting protein 1 kinase inhibition emerges as a promising therapeutic strategy.
- * Combination therapies targeting multiple cell death pathways may offer superior benefits.
Conclusions:
- * Regulated necrosis pathways are significant contributors to kidney disease pathogenesis.
- * Targeting receptor-interacting protein 1 kinase is a viable therapeutic approach.
- * Combination inhibition of cell death pathways holds potential for improved patient outcomes and cures in kidney diseases.
More Related Videos
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
455
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
455
01:28Chronic Kidney Disease III: Interprofessional Care
586
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:20Acute Kidney Injury V: Interprofessional Care
450
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
450
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:30Overview of Cell Death
10.9K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.9K